Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immunogenicity of Plant-Produced Human Papillomavirus (HPV) Virus-Like Particles (VLPs)
Authors
Keywords
-
Journal
Vaccines
Volume 8, Issue 4, Pages 740
Publisher
MDPI AG
Online
2020-12-08
DOI
10.3390/vaccines8040740
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HPV VLPs as Scaffolds for Vaccine Design
- (2019) Thomas Jordan et al. BIOPHYSICAL JOURNAL
- Virus‐like particles for vaccination against cancer
- (2019) Mona O. Mohsen et al. Wiley Interdisciplinary Reviews-Nanomedicine and Nanobiotechnology
- Substitution of Human Papillomavirus Type 16 L2 Neutralizing Epitopes Into L1 Surface Loops: The Effect on Virus-Like Particle Assembly and Immunogenicity
- (2019) Aleyo Chabeda et al. Frontiers in Plant Science
- A canine adenovirus type 2 vaccine vector confers protection against foot-and-mouth disease in guinea pigs
- (2018) Annebel R. De Vleeschauwer et al. VACCINE
- Novel expression of immunogenic foot-and-mouth disease virus-like particles in Nicotiana benthamiana
- (2018) Varusha Pillay Veerapen et al. VIRUS RESEARCH
- A call for the introduction of gender-neutral HPV vaccination to national immunisation programmes in Africa
- (2018) Onyema Greg Chido-Amajuoyi et al. Lancet Global Health
- The global burden of women’s cancers: a grand challenge in global health
- (2017) Ophira Ginsburg et al. LANCET
- Molecular pharming — VLPs made in plants
- (2016) Johanna Marsian et al. CURRENT OPINION IN BIOTECHNOLOGY
- Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis
- (2016) Laia Bruni et al. Lancet Global Health
- Scalable Production of HPV16 L1 Protein and VLPs from Tobacco Leaves
- (2016) Maryam Zahin et al. PLoS One
- Recent progress in vaccination against human papillomavirus-mediated cervical cancer
- (2015) Sara J. McKee et al. REVIEWS IN MEDICAL VIROLOGY
- Identification, Characterization and Down-Regulation of Cysteine Protease Genes in Tobacco for Use in Recombinant Protein Production
- (2015) Kishor Duwadi et al. PLoS One
- Immunogenic assessment of plant-produced human papillomavirus type 16 L1/L2 chimaeras
- (2013) Catherine B. Pineo et al. PLANT BIOTECHNOLOGY JOURNAL
- Characterization of virus-like particles in GARDASIL® by cryo transmission electron microscopy
- (2013) Qinjian Zhao et al. Human Vaccines & Immunotherapeutics
- Plant-derived virus-like particles as vaccines
- (2012) Qiang Chen et al. Human Vaccines & Immunotherapeutics
- GMP issues for recombinant plant-derived pharmaceutical proteins
- (2011) Rainer Fischer et al. BIOTECHNOLOGY ADVANCES
- A Murine Genital-Challenge Model Is a Sensitive Measure of Protective Antibodies against Human Papillomavirus Infection
- (2011) S. Longet et al. JOURNAL OF VIROLOGY
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Plant-made vaccines for humans and animals
- (2010) Edward P. Rybicki PLANT BIOTECHNOLOGY JOURNAL
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- Human Papillomavirus (HPV) Vaccines: Limited Cross‐Protection against Additional HPV Types
- (2009) Rolando Herrero JOURNAL OF INFECTIOUS DISEASES
- One-step chromatographic purification of human papillomavirus type 16 L1 protein from Saccharomyces cerevisiae
- (2009) Hyoung Jin Kim et al. PROTEIN EXPRESSION AND PURIFICATION
- An HPV 16 L1-based chimeric human papilloma virus-like particles containing a string of epitopes produced in plants is able to elicit humoral and cytotoxic T-cell activity in mice
- (2009) Georgina De la Rosa et al. Virology Journal
- Human papillomavirus L1 protein expressed in tobacco chloroplasts self-assembles into virus-like particles that are highly immunogenic
- (2008) Alicia Fernández-San Millán et al. PLANT BIOTECHNOLOGY JOURNAL
- An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
- (2008) John T. Schiller et al. VACCINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started